Advertisement

Koronare Herzkrankheit

  • Gerhard Riecker

Zusammenfassung

Die koronare Herzkrankheit (KHK) repräsentiert ein klinisches Syndrom aus Angina pectoris, Myokardinfarkt und konsekutiven Folgeerkrankungen (Herzinsuffizienz, Rhythmusstörungen, plötzlicher Herztod, Papillarmuskeldysfunktion und Wandkontraktionsstörungen). Die pathophysiologische Basis ist eine Limitierung der myokardialen O2-Verfügbarkeit durch Einschränkung der Koronarreserve und der regionalen sowie globalen myokardialen O2-Zufuhr. Ursächlich liegt in der Mehrzahl der Fälle (ca. 80–95%) eine stenosierende Koronarsklerose der großen extramuralen Koronararterien zugrunde, in ca. 5–20% sind Gefäßerkrankungen der kleinen, intramuralen Arterien und Arteriolen im Rahmen internistischer Erkrankungen sowie extrakoronare Ursachen ausschlaggebend. Die koronare Herzkrankheit ist eine der häufigsten Krankheiten überhaupt. 1982 gab es in der Bundesrepublik Deutschland ca. 480000 koronarkranke Patienten, d. h. auf 125 Einwohner kommt ein Patient mit KHK. Die Dunkelziffer ist beträchtlich. Herz- und Kreislauferkrankungen sind die häufigsten Todesursachen. 1985 traten 51% aller Todesfälle auf dem Boden von Erkrankungen des Herz-Kreislauf-Systems auf. An zweiter Stelle folgen mit 23,1% Krebserkrankungen, an dritter Stelle mit 6,3% Krankheiten der Atmungsorgane. Die absolute Häufigkeit der KHK hat in den letzten Jahrzehnten erheblich zugenommen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bretschneider HJ (1967) Aktuelle Probleme der Koronardurchblutung und des Myokardstoffwechsels. Regensburg Aerztl Fortbild 1: 11Google Scholar
  2. 2.
    Pary CH (1799) An inquiry into the symtoms and causes of syncope anginosa commonly called angina pectoris. LondonGoogle Scholar
  3. 3.
    Dietrich H, Schwiegk H (1928) Angina pectoris und Anoxie des Herzmuskels. Z Klin Med 125: 195Google Scholar
  4. 4.
    Seidel D, Cremer P, Thiery J (1985) Plasmalipoproteine und Atherosklerose. Int Welt 5: 114–124Google Scholar
  5. 5.
    Strauer BE (1988) Angina pectoris bei normalem Koronarangiogramm, ein differentialdiagnostisches Problem. In: Riecker G (Hrsg) Koronare Herzkrankheit. Springer, Berlin Heidelberg New York Tokyo, S 93–105Google Scholar
  6. 6.
    Riecker G (1973) Wertigkeit klinischer Belastungsprüfungen bei koronarer Herzkrankheit. Dtsch Med Wochenschr 98: 891PubMedGoogle Scholar
  7. 7.
    Lichtlen PR (1979) Koronarangiographie. Straube, ErlangenGoogle Scholar
  8. 8.
    Strauer BE, Bolte HD, Heimburg P, Riecker G (1975) Zur koronaren Herzkrankheit I.: Eine korrelative Studie über Hämodynamik und Kontraktilität an 110 Patienten. Z Kardiol 64: 300PubMedGoogle Scholar
  9. 9.
    Strauer BE, Bolte HD, Heimburg P, Riecker G (1975) Zur koronaren Herzkrankheit II.: Eine Analyse diastolischer Druck-Volumen-Beziehungen und linksventrikulärer Dehnbarkeit an 110 Patienten. Z Kardiol 64: 311PubMedGoogle Scholar
  10. 10.
    The Veterans Administration Coronary artery bypass surgery cooperative study (1984) N Engl J Med 311: 1333Google Scholar
  11. 11.
    CASS (1983) Principal Investigators and their associates. Coronary artery surgery study (CASS). Circulation 68: 939Google Scholar
  12. 12.
    Varnauskas E and the European Coronary Surgery Study Group (1988) 12-years follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 329: 332Google Scholar
  13. 13.
    Strauer BE (1983) Das Hochdruckherz, 2. Aufl. Springer, Berlin Heidelberg New YorkGoogle Scholar
  14. 14.
    Rutsch W, Schartl M, Schmutzler H (1987) Die Europäischen rt-PA-Studien beim akuten Myokardinfarkt. In: Bono DP de, Brochier ML, Hugenholtz PG, Kübler W, Verstraete M (Hrsg) Thrombolytische Therapie des akuten Herzinfarkts. Springer, Berlin Heidelberg New York, Tokyo, S 75–99Google Scholar
  15. 15.
    Kannel WB, Feinleib M (1972) Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol 29: 154PubMedGoogle Scholar
  16. 16.
    Vogel H (1985) Antithrombotische Behandlung nach Myokardinfarkt. In: Tiesner V, Matthias FR (Hrsg) Gerinnungsphase Therapie bei Myokardinfarkt. 28. Hamburger Symposium Blutgerinnung. S 133-157Google Scholar
  17. 17.
    Nees S (1989) The adenosine hypothesis of metabolic regulation of coronary flow in the light of newly recog-nized properties of the coronary endothelium. Z Kardiol 78/6 [Suppl]: 42–49Google Scholar
  18. 18.
    Spalteholz W (1907) Die Koronararterien des Herzens. Verh Anat Ges 21: 141–152Google Scholar
  19. 19.
    Bassingthwaighte JB, Yipintsoi T, Harvey RB (1974) Microvasculature of the dog left ventricular myocardium. Microvasc Res 7: 229–249PubMedGoogle Scholar
  20. 20.
    Feigl EA (1983) Coronary Physiology. Physiol Rev 63: 1–205PubMedGoogle Scholar
  21. 21.
    Pohl U, Holtz J, Busse R, Bassenge E (1986) Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 8: 37–44PubMedGoogle Scholar
  22. 22.
    Furchgott RF (1983) Role of endothelium in response of vascular smooth muscle. Circ Res 53: 557–573PubMedGoogle Scholar
  23. 23.
    Berne RM (1980) The role of adenosine in the regulation of coronary blood flow. Circ Res 47: 807–813PubMedGoogle Scholar
  24. 24.
    Becker BF, Gerlach E (1987) Uric acid, the major catabolite of cardiac adenine nucleotides and adenosine, originates in the coronary endothelium. In: Gerlach E, Becker BF (eds) Topics and perspectives in adenosine research. Springer, Berlin Heidelberg New York Tokyo, pp 209–222Google Scholar
  25. 25.
    Zimmer H-G, Trendelenburg C, Kammermeier H, Gerlach E (1973) Denovo-synthesis of myocardial adenine nucleotides in the rat. Acceleration during recovery from oxygen deficiency. Circ Res 32: 635–642PubMedGoogle Scholar
  26. 26.
    Daut J, Mehrke G, Nees S, Newman WH (1988) Passive electrical properties and electrogenic sodium transport of cultured guinea-pig coronary endothelial cells. J Physiol 402: 237–254PubMedGoogle Scholar
  27. 27.
    Gonzales JP, Botvinick EH, Dunn R (1982) The late prognostic value of acute scintigraphic measurement of myocardial infarction. Circulation 66: 960–971Google Scholar
  28. 28.
    Hirzel HO, Senn M, Nuesch K, Buettner C, Pfeiffer A, Hess OM, Krayenbuehl HP (1984) Thallium-201 scintigraphy in complete left bundle branch block. Am J Cardiol 53: 764–769PubMedGoogle Scholar
  29. 29.
    Hör G, Kanemoto N (1981) 201-T1 myocardial scintigraphy: current status in coronary artery disease, results of sensitivity/specificity in 3092 patients and clinical recommendations. Nucl Med 20: 136–147Google Scholar
  30. 30.
    Schelbert HR, Buxton D (1988) Insights into coronary artery disease gained from metabolic imaging. Circulation 78: 496–505PubMedGoogle Scholar
  31. 31.
    Büll U, Stirner H, Dahl J vom (1987) Quantitive evaluation of myocardial stress/rest 201-Tl SPECT: results of a ROI-based method in 108 patients with CHD. Nucl Med 26: 234–240Google Scholar
  32. 32.
    Detrano R, Janosi, A, Lyons KP, Marcondes G, Abbassi N, Froelicher VF (1988) Factors affecting sensitivity and specificity of a diagnostic test: the exercise Thallium scintigram. Am J Med 84: 699–710PubMedGoogle Scholar
  33. 33.
    Diamond GA, Forrester JF (1979) Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 300: 1350–1358PubMedGoogle Scholar
  34. 34.
    Schicha H (1986) Nuclearmedizinische Diagnostik in der Kardiologie. Intern Welt 2: 41–51Google Scholar
  35. 35.
    Train KF van, Berman DS, Garcia EV (1986) Quantitative analysis of stress thallium-201 myocardial scintigrams: a multicenter trial. J Nucl Med 27: 17–25PubMedGoogle Scholar
  36. 36.
    Nienaber CA, Spielmann RP, Salge D (1987) Nichtinvasive Identifizierung von kollateralisiertem Myokard durch 201-Thallium-Tomographie in Vasodilation und Redistribution. Z Kardiol 76: 612–20PubMedGoogle Scholar
  37. 37.
    Wieshammer S, Henze E (1987) Wann soll bei Verdacht auf koronare Herzerkrankung eine Thalliumszintigraphie durchgeführt werden? Inn Med 14:169–173Google Scholar
  38. 38.
    Zaret BL, Wackers FJ (1987) Radionuclide methods for evaluating the results of thrombolytic therapy. Circulation 76 [Suppl]: II–8–17Google Scholar
  39. 39.
    Arnim T von (1988) Die stumme Myokardischämie. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  40. 40.
    Arnim T von, Höfling B, Schreiber MA (1985) Characteristics of episodes of ST elevation or ST depression during ambulatory monitoring in patients subsequently undergoing coronary angiography. Br Heart J 54: 484–488Google Scholar
  41. 41.
    Arnim T von (1987) Silent ischaemia in patients with coronary heart disease: prevalence and prognostic implications. Eur Heart J 8 [Suppl] G: 115–118PubMedGoogle Scholar
  42. 42.
    Berman DS, Rozanski A, Knoebel SB (1987) The detection of silent ischemia: cautions and precautions. Circulation 75: 101–105PubMedGoogle Scholar
  43. 43.
    Multiple Risk Factor Intervention Trial Research Group (1987) Exercise electrocardiogram and coronary heart disease mortality in the multiple risk factor intervention trial. Am J Cardiol 55: 16–24Google Scholar
  44. 44.
    Roelandt J, Lubsen J, Janse MJ (1984) Sudden death during longterm ambulatory monitoring. Eur Heart J 5: 7–20PubMedGoogle Scholar
  45. 45.
    Cucu F (1980) Philogenetic evolution of the coronary artery intima and its relevance to atherosclerosic involvement. Med Interne 18: 99–104PubMedGoogle Scholar
  46. 46.
    Davies MJ, Thomas AC (1985) Plaque fissuring — the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 53: 363–373PubMedGoogle Scholar
  47. 47.
    Falk E (1985) Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 71: 699–708PubMedGoogle Scholar
  48. 48.
    Hort W, Moosdorf R, Kalbfleisch H, Köhler F, Milzner-Schwarz U, Frenzel H (1977) Postmortale Untersuchungen über Lokalisation und Form der stärksten Stenosen in den Koronararterien und ihre Beziehung zu den Risikofaktoren. Z Kardiol 66: 333–340PubMedGoogle Scholar
  49. 49.
    Yates JD, Kirsh MM, Sodeman TM, Walton JA, Brymen JF (1974) Coronary ostial stenosis. A complication of aortic valve replacement. Circulation 44: 530–534Google Scholar
  50. 50.
    Hort W (1990) Morphological aspects. In: Jacob R, Seipel L, Zucker JH (eds) Cardiac dilatation. Fischer Stuttgart, S. 3–17Google Scholar
  51. 51.
    Reinecke P, Hort W (1988) Untersuchungen über das Wachstum der Coronararterienäste. Morphometrische Untersuchungen an Korrosionspräparaten des R. interventricularis der A. coronaria sinistra beim Schwein und Ferkel. Z Kardiol 77: 299–304PubMedGoogle Scholar
  52. 52.
    Böger A, Hort W (1977) Qualitative und quantitative Untersuchungen am Lymphgefäßsystem des Mäuseherzens. Basic Res Cardiol 72: 510–529PubMedGoogle Scholar
  53. 53.
    Factor SM, Cho S (1985) Smooth muscle contraction bands in the media of coronary arteries: A postmortem marker of antemortem coronary spasm? J Am Coll Cardiol 6: 1329–1337PubMedGoogle Scholar
  54. 54.
    Roberts WC, Curry RC, Isner JM, Waller BF, McManus BM, Mariani-Constantini R, Ross AM (1982) Sudden death in Prinzmetal’s angina with coronary spasm documented by angiography. Analysis of three necropsy patients. Am J Cardiol 50: 203–210PubMedGoogle Scholar
  55. 55.
    Ross R (1986) The pathogenesis of atherosclerosis — an update. N Engl J Med 314: 488–500PubMedGoogle Scholar
  56. 56.
    Ross R, Glomset A (1976) The pathogenesis of atherosclerosis. N Engl J Med 295: 369–377PubMedGoogle Scholar
  57. 57.
    Deutsche Gesellschaft für Herz-und Kreislaufforschung, Kommission Klinische Kardiologie (1987) Empfehlungen für die Durchführung der perkutanen transluminalen Koronarangioplastie (PTCA). Z Kardiol 76: 382Google Scholar
  58. 58.
    Grüntzig AR (1976) Perkutane Dilatation von Koronarstenosen — Beschreibung eines neuen Kathetersystems. Klin Wochenschr 54: 543–545PubMedGoogle Scholar
  59. 58 a.
    Grüntzig AR (1978) Transluminal dilatation of coronary artery stenosis. Lancet I: 263Google Scholar
  60. 58 b.
    Höfling B, Reichart B, Simpson JB (1989) Ballondilatation und Weiterentwicklungen. R. S. Schulz Verlag StarnbergGoogle Scholar
  61. 59.
    Simpson JB, Baim DS, Robert EW, Harrison DC (1982) A new catheter system for coronary angioplasty. Am J Cardiol 46: 1216Google Scholar
  62. 59 a.
    Höfling B (1988) Die perkutane transluminale Koronarangioplastie (PTCA): Entscheidungskriterien und Ergebnisse. In: G. Riecker (Hrsg.) Koronare Herzkrankheit. Springer, Berlin HeidelbergGoogle Scholar
  63. 60.
    Block PC, Myler RK, Stertzer S, Fallon JT (1981) Morphology after transluminal angioplasty in human beings. N Engl J Med 305: 382PubMedGoogle Scholar
  64. 61.
    Council on Scientific Affairs (1984) Percutaneous transluminal angioplasty. JAMA 251: 764–768Google Scholar
  65. 62.
    Meyer J, Merx W, Schmitz H et al. (1982) Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation 66: 905PubMedGoogle Scholar
  66. 63.
    Meyer J, Schmitz H, Kiesslich T et al. (1983) Percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris: analysis of early and late results. Am Heart J 106: 973PubMedGoogle Scholar
  67. 64.
    TIMI Research Group (1988) Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction JAMA 260: 2849–2858Google Scholar
  68. 65.
    Detre K, Holubkov R, Kelsey S, Cowley M, Kent K, Williams D, Myler R et al. (1988) Percutaneous transluminal coronary angioplasty in 1985–1986 and 1977–1981. N Engl J Med 318: 265–270PubMedGoogle Scholar
  69. 66.
    Daly LE, Mulcahy R, Graham IM, Hickey N (1983) Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. Br Med J 287: 324–326Google Scholar
  70. 67.
    Yusuf S, Wittes J, Friedman L (1988) Overview of results of randomized clinical trials in heart disease. II. Instable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 260: 2259–2263PubMedGoogle Scholar
  71. 68.
    Cruickshank JM, Thorp JM, Zacharias FJ (1987) Benefits and potential harm of lowering high blood pressure. Lancet I: 581–583Google Scholar
  72. 69.
    Wikstrand J, Warnold I, Olsson G et al (1988) Primary prevention with metoprolol in patients with hypertension — mortality results from the MAPHY study. JAMA 259: 1976–1982PubMedGoogle Scholar
  73. 70.
    Hjalmarson A (1988) International beta-blocker review in acute and postmyocardial infarction. Am J Cardiol 61: 26B–29BPubMedGoogle Scholar
  74. 71.
    Yusuf S, Wittes J, Friedman L (1988) Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 260: 2088–2093PubMedGoogle Scholar
  75. 72.
    Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E (1988) Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 319: 80–86PubMedGoogle Scholar
  76. 73.
    Antiplatelet Trialists’ Collaboration (1988) Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 296: 320–331Google Scholar
  77. 74.
    Steering Committee of the Physicians’ Health Study Research Group (1988) Preliminary report: Findings from the aspirin component of the ongoing physicians’ health study. N Engl J Med 318: 262–264Google Scholar
  78. 75.
    Neri Serneri GG, Gensini GF, Carnovali M et al (1987) Effectiveness of low-dose heparin in prevention of myocardial reinfarction. Lancet I: 937–942Google Scholar
  79. 76.
    Oldridge NB, Guyatt GH, Fischer ME, Rimm AA (1988) Cardiac rehabilitation after myocardial infarction — combined experience of randomized clinical trials. JAMA 260: 945–950PubMedGoogle Scholar
  80. 77.
    Powell LH, Thoresen CE (1988) Effects of type A behavioral counseling and severity of prior acute myocardial infarction on survival. Am J Cardiol 62: 1159–1163PubMedGoogle Scholar
  81. 78.
    Ruberman W, Weinblatt E, Goldberg JD, Chaudhary BS (1984) Psychosocial influences on mortality after myocardial infarction. N Engl J Med 311: 552–559PubMedGoogle Scholar
  82. 79.
    Gruppo italiano per lo studio della streptochi-nasi nell’ infarto miocardico (GISSI) (1987) Long-term effects of intravenous thrombolysis in acute infarction: final report of the GISSI study. Lancet II: 871–874Google Scholar
  83. 80.
    ISIS-2 (Second international study of infarct survival) collaborative group (1988) Randomized trial of intrave-nous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet II: 349–360Google Scholar
  84. 81.
    AIMS Trial Study Group (1988) Effect of intravenous APSAC on mortality after acute myocardial infarction — preliminary report of a placebocontrolled clinical trial. Lancet I: 545–549Google Scholar
  85. 81 a.
    Höfling B, Pölnitz AV (1990) Invasive Strategy for Treatment of Myocardial Infarction. J Cardiovasc Pharmacol 16 (Suppl 5): 120–122Google Scholar
  86. 82.
    Wilcox RG, Olsson CG, Skene AM et al (1988) Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction — Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet II: 525–530Google Scholar
  87. 83.
    Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension: Principal results. Br Med J 291: 97–104Google Scholar
  88. 84.
    Bartel AG, Chen JT, Peter RH, Behar VS, Kong Y, Lester RG (1974) The significance of coronary calcification detected by fluoroscopy. Circulation 49: 1247PubMedGoogle Scholar
  89. 85.
    Hamby RJ, Tabrah F, Wisoff BG, Hartenstein ML (1974) Coronary artery calcification: Clinical implications and angiographic correlates. Am Heart J 87: 566Google Scholar
  90. 86.
    Hartmann FX (1981) Häufigkeit und Schweregrad der Koronararterienverkalkung bei Patienten mit angiographisch nachgewiesener koronarer Herzerkrankung. Inauguraldissertation, LMU MünchenGoogle Scholar
  91. 87.
    Prendl S (1981) Die Bedeutung der Koronararterienverkalkung für die Diagnose einer koronaren Herzerkrankung. Inauguraldissertation, LMU MünchenGoogle Scholar
  92. 88.
    Brundage BH, Spigos D (1985) The future of computed tomography for the evaluation of ischemic heart disease. Int J Cardio 17: 187Google Scholar
  93. 89.
    Lipton MJ, Brundage BH, Higgins CG, Boyd DP (1986) Clinical applications of dynamic computed tomography. Prog Cardiovasc Dis 28: 349PubMedGoogle Scholar
  94. 90.
    Rienmüller R, Ontyd J, Krappel W, Strauer B-E (1983) Infarktbedingte Veränderungen des linksventrikulären Myokards in der kardialen Computertomographie. Fortschr Röntgenstr 4/138: 391–518Google Scholar
  95. 91.
    Rienmüller R, Seiderer M, Doliva R, Kemkes BM, Lissner J (1986) Pericardial and congestive heart failure. Diagnostic with CT-and MR Imaging. Ann Radiol 29: 95–100PubMedGoogle Scholar
  96. 92.
    Martin MJ, Hulley SB, Browner WS (1986) Serum cholesterol, blood pressure and mortality: implications from a cohort of 361662 men. Lancet 8513: 933–936Google Scholar
  97. 93.
    Frick MH, Elo O, Haapa K (1987) Helsinki Heart Study: primary prevention trial with gemfibrozil in middle agcol men with dyslipidemia. N Engl J Med 317: 1237–1245PubMedGoogle Scholar
  98. 94.
    Preliminary report: findings from the aspirin component of the ongoing physicians’ health study (1988) The Steering Committee of the physicians’ health study research group. N Engl J Med 318: 262–264Google Scholar
  99. 95.
    Theroux P, Ouimet H, McCans J et al (1988) Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 319: 1105–1111PubMedGoogle Scholar
  100. 96.
    Smith P, Arnesen H, Holme I (1990) The effect of warfarin on mortality and reinfarction after myocardial in-farction. N Engl J Med 323: 147–152PubMedGoogle Scholar
  101. 97.
    Friedman M, Rosenman RH (1959) Association of specific overt behavior pattern with blood and cardiovascular findings. JAMA 169: 1286–1296Google Scholar
  102. 98.
    Coronary-prone behavior and coronary heart disease: a critical review (1981) The Review Panel on coronaryprone behavior and coronary heart disease. Circulation 63: 1199–1215Google Scholar
  103. 99.
    Friedman M., Thoresen CE, Gill JJ et al (1986) Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project. Amer Heart J 112: 653–664PubMedGoogle Scholar
  104. 100.
    Ragland DR, Brand RJ (1988) Type A behaviour and mortality from coronary heart disease. N Engl J Med 318: 65–69PubMedGoogle Scholar
  105. 101.
    Kallio V, Hämäläinen H (1979) Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarction. Lancet 8152: 1091–1094Google Scholar
  106. 102.
    Kesteloot H (1987) Cardiovascular risk factors and mortality in women. Herz 12: 248–254PubMedGoogle Scholar
  107. 103.
    Scanu AM, Fless GM (1990) Lipoprotein (a) — Heterogeneity and Biological Relevance. J Clin Invest 85: 1709–1715PubMedGoogle Scholar
  108. 104.
    Utermann G (1989) The Mysteries of Lipoprotein (a). Science 246: 904–910PubMedGoogle Scholar
  109. 105.
    The Danish Study Group on Verapamil in Myocardial Infarction (1990) Effect of Verapamil on Mortality and Major Events After Acute Myocardial Infarction (The Danish Verapamil Infarction Trial II-DAVITII). Am J Cardiol 66: 779–785Google Scholar
  110. 106.
    Blankenhorn DH, Nessim SA, Johnson RL et al (1987) Beneficial effects of combined colestipol-niacin therapy on coronary arteriosclerosis and coronary venous bypass grafts. JAMA 257: 3233–40PubMedGoogle Scholar
  111. 107.
    Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin J-T, Kaplan C, Zhao X-Q, Bisson BD, Fitzpatrick VF, Dodge HT (1990) Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323: 1289–1298PubMedGoogle Scholar
  112. 108.
    Reithmann C, Werdan K (1990) Regulation der Beta-Rezeptoren — Praktische Konsequenzen für die Therapie. Internist 31: 625–631PubMedGoogle Scholar
  113. 109.
    Nidorf SM, Parsons RW, Thompson PL, Jamrozik KD, Hobbs MST (1990) Reduced risk of death at 28 days in patients taking a betablocker before admission to hospital with myocardial infarction. Brit Med J 300: 71–74PubMedGoogle Scholar
  114. 110.
    Fitzgerald LJ, Bennett ED (1990) The effects of oral isosorbide 5-monomitrate on mortality following acute myocardial infarction: A multicentre study. Eur Heart J 11: 120–126PubMedGoogle Scholar
  115. 111.
    O’Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenberger RS, Hennekens CH (1989) An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 80: 234–244PubMedGoogle Scholar
  116. 112.
    Eaker ED, Castelli WP (1988) Type A behavior and mortality from coronary disease in the Framingham study. N Engl J Med 319: 1480–1481PubMedGoogle Scholar
  117. 113.
    Case RB, Heller SS, Case NB, Moss AJ and the Multicenter Post-Infarction Research Group (1985) Type A behavior and survival after acute myocardial infarction. N Engl J Med 312: 737–741PubMedGoogle Scholar
  118. 114.
    Pekkanen J, Linn S, Heiss G, Suchindran C, Leon A, Rifkind BM, Tyroler HA (1990) Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 322: 1700–1707PubMedGoogle Scholar
  119. 115.
    Held PH, Yusuf S, Furberg CD (1989) Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Brit Med J 299: 1187–1192PubMedGoogle Scholar
  120. 116.
    Sytkowski PA, Kannel WB, D’Agostino RB (1990) Changes in risk factors and the decline in mortality from cardiovascular disease — The Framingham Heart Study. N Engl J Med 322: 1635–1641PubMedGoogle Scholar
  121. 117.
    Cremer P, Muche R (1990) Göttinger Risiko-, Inzidenz-und Prävalenzstudie (GRIPS) — Empfehlungen zur Prävention der koronaren Herzkrankheit. Therapeutische Umschau 47: 482–491PubMedGoogle Scholar
  122. 118.
    Assmann G, Schulte H (1989) Diabetes mellitus and hypertension in the elderly: concomitant hyperlipidemia and coronary heart disease risk. Am J Cardiol 63: 33H–37HPubMedGoogle Scholar
  123. 119.
    Meyer J (1991) Der akute Myokardinfarkt — Invasive Therapieverfahren-. 21. Ludwig-Heilmeyer-Symposium, 22.-24.11. 1990, Köln. Thieme-StuttgartGoogle Scholar
  124. 120.
    Bleifeld W, Hamm ChW (1987) Herz und Kreislauf. Springer, Berlin HeidelbergGoogle Scholar
  125. 121.
    Castelli WP (1984) Epidemiology of Coronary Heart Disease. Am J Med, Febr. 27 S. 4-12Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • Gerhard Riecker
    • 1
  1. 1.Medizinische Klinik IKlinikum Großhadern, Universität MünchenMünchenDeutschland

Personalised recommendations